Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Stoke Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 352.5M, a 53.90% increase year-over-year.
- Stoke Therapeutics Inc. shareholder equity for 2025 were 352.5M, a 53.90% increase from 2024.
- Stoke Therapeutics Inc. shareholder equity for 2024 were 229.0M, a 43.53% increase from 2023.
- Stoke Therapeutics Inc. shareholder equity for 2023 were 159.6M, a 13.68% decrease from 2022.
- Stoke Therapeutics Inc. shareholder equity for 2022 were 184.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Stoke Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $352 |
| 2024 | $229 |
| 2023 | $160 |
| 2022 | $185 |
| Stoke Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $352 |
| 2024-12-31 | $229 |
| 2023-12-31 | $160 |
| 2022-12-31 | $185 |
Stoke Therapeutics Inc. Shareholder Equity — FAQ
Stoke Therapeutics Inc. (STOK) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STOK's shareholder equity history?
The chart and table above show Stoke Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.